TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 103 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2015. The put-call ratio across all filers is 0.74 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $337,000 | -46.0% | 3,944 | -37.6% | 0.03% | -30.2% |
Q1 2018 | $624,000 | +25.6% | 6,316 | +33.2% | 0.04% | -21.8% |
Q4 2017 | $497,000 | +83.4% | 4,742 | +149.6% | 0.06% | +139.1% |
Q3 2015 | $271,000 | -83.4% | 1,900 | -83.2% | 0.02% | -87.4% |
Q2 2015 | $1,628,000 | – | 11,330 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
FORT, L.P. | 9,672 | $730,000 | 0.14% |
CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |